| HEPES | 2-[4-(2-Hydroxyethyl)-1-piperazinyl] ethanesulfonic acid |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide |
| CTAs | Cancer testes antigens |
| CD | Clusters of Differentiation |
| CTLA-4 | Cytotoxic T lymphocyte associated antigen-4 |
| EOC | Epithelial ovarian cancer |
| FACS | Fluorescent-activated cell sorting |
| Her2 | Human epidermal growth factor receptor 2 |
| MHC I | Major histocompatibility class I molecules |
| MUC16 | Mucin 16 |
| NHMRC | National health and medical research council |
| NK | Natural killer |
| NY-ESO-1 | New York esophageal squamous cell carcinoma 1 |
| OC | Ovarian cancer |
| PBS | Phosphate buffered saline |
| PD-L1 | Programed cell death ligand-1 |
| PD-1 | Programed cell death protein-1 |
| RPMI | Roswell Park Memorial Institute |
| STAT3 | Signal transducer and activator of transcription 3 |
| Sp17 | Sperm protein 17 |
| TNFRII | Tumor necrosis factor receptor II |
| TP53 | Tumor protein p53 |